Simcere Pharmaceutical Group (NYSE: SCR) announced today the successful completion of Endostar Phase IV clinical study at a conference in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE